-transparent.png){kind=logo}
Discovery of a Series of 5,11-Dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-ones as Selective PI3K-δ/γ Inhibitors. 2016
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
Department of Cancer Biology, Dana-Farber Cancer Institute , Boston, Massachusetts 02215, United States.
Dual inhibition of PI3K-δ and PI3K-γ is an established therapeutic strategy for treatment of hematological malignancies. Reported molecules targeting PI3K-δ/γ selectively are chemically similar and based upon isoquinolin-1(2H)-one or quinazolin-4(3H)-one scaffolds. Here we report a chemically distinct series of potent, selective PI3K-δ/γ inhibitors based on a 5,11-dihydro-6H-benzo[e]pyrimido[5,4-b][1,4]diazepin-6-one scaffold with comparable biochemical potency and cellular effects on PI3K signaling. We envisage these molecules will provide useful leads for development of next-generation PI3K-δ/γ targeting therapeutics.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
July 2020,
Journal of medicinal chemistry,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
September 2020,
Journal of medicinal chemistry,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
July 2010,
Journal of combinatorial chemistry,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
March 2011,
ACS medicinal chemistry letters,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
November 2015,
Molecular diversity,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
November 2017,
European journal of medicinal chemistry,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
December 1982,
Il Farmaco; edizione scientifica,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
November 2022,
ACS medicinal chemistry letters,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
October 2020,
ACS omega,
Fleur M Ferguson, and
Jing Ni, and
Tinghu Zhang, and
Bethany Tesar, and
Taebo Sim, and
Nam Doo Kim, and
Xianming Deng, and
Jennifer R Brown, and
Jean J Zhao, and
Nathanael S Gray
April 2008,
Bioorganic & medicinal chemistry letters,
